Related Experiment Videos
[Intrauterine management of Rh-alloimmunization]
Orvosi Hetilap
|March 31, 1996
Summary
This study details invasive management for Rh alloimmunisation in pregnancy using ultrasound-guided fetal blood sampling and intrauterine transfusions. This approach resulted in 25 healthy newborns from 34 pregnancies, offering a vital strategy for this high-risk condition.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Immunology
Context:
- Rh alloimmunisation poses a significant risk to pregnancies, potentially leading to fetal anemia and hydrops fetalis.
- Effective management strategies are crucial to improve fetal outcomes in affected pregnancies.
Purpose:
- To describe the invasive management strategy for Rh alloimmunisation in pregnancy.
- To evaluate the efficacy and complications of ultrasound-guided fetal blood sampling and intrauterine transfusions.
Summary:
- The study involved 34 pregnancies managed with invasive procedures, including amniocentesis, fetal blood sampling, and intrauterine intravascular blood transfusions.
- Procedures were ultrasound-guided, with fetal blood sampling via umbilical vessel puncture and transfusions using maternal or specially prepared donor blood.
- Complications were detailed, and 25 out of 34 newborns were healthy, an acceptable outcome given the condition's high mortality rate.
Impact:
- The findings support the necessity of fetal blood sampling and intrauterine transfusion techniques in managing Rh alloimmunised pregnancies.
- This invasive approach offers a viable strategy to improve fetal survival rates in Rh alloimmunisation.
- No maternal complications were reported, highlighting the safety of the procedures for the mother.